58 results
8-K
EX-99.1
LCTX
Lineage Cell Therapeutics, Inc.
8 Aug 24
Lineage Cell Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
4:10pm
of the team at Roche and Genentech, as well as their ongoing leadership of the OpRegen program through presentations at scientific conferences
8-K
EX-99.1
LCTX
Lineage Cell Therapeutics, Inc.
9 May 24
Lineage Cell Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
4:10pm
, an initiative at the Bill and Melinda Gates Foundation Strategic Investment Fund, and most recently served in the leadership team at NanoString Technologies. She
8-K
g2aka120 zzk
26 Mar 21
Departure of Directors or Certain Officers
5:22pm
8-K
7y8fug lcw35rg
20 Jan 21
Departure of Directors or Certain Officers
4:30pm
8-K
EX-99.1
e20km3h
12 Mar 20
Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update
4:15pm
8-K
EX-99.1
ghn231kqg4cs
8 Aug 19
Results of Operations and Financial Condition
4:10pm
424B3
5gj49
4 Feb 19
Prospectus supplement
5:52pm